Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis
Abstract The treatment of pediatric myocarditis is controversial, and the benefits of intravenous immunoglobulin (IVIG) are inconclusive due to limited data. We searched studies from PubMed, MEDLINE, Embase, and Cochrane Library databases since establishment until October 1st, 2018. Thirteen studies...
Guardado en:
Autores principales: | Chun-Yu Yen, Miao-Chiu Hung, Ying-Chi Wong, Chia-Yuan Chang, Chou-Cheng Lai, Keh-Gong Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/561ed73bb38449be864518473353b31b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
por: S. A. Sel'kov, et al.
Publicado: (2014) -
Intravenous Immunoglobulin and its Complications
por: I Mohammadzadeh
Publicado: (2011) -
INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
por: V. A. Lazanovich, et al.
Publicado: (2014) -
Lyme Borreliosis as a Cause of Myocarditis in Pediatric Age
por: Andreia D. Constante, et al.
Publicado: (2021) -
Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis
por: Laura Díez-Porras, et al.
Publicado: (2020)